" /> Rilimogene Galvacirepvec - CISMeF





Preferred Label : Rilimogene Galvacirepvec;

NCIt synonyms : rVaccinia-Prostate-Specific Antigen/TRICOM Vaccine; Vaccinia-PSA-TRICOM Vaccine; Recombinant Vaccinia-PSA(L155)-TRICOM Vaccine; rVaccinia-PSA(L155)-TRICOM Vaccine; Recombinant Vaccinia-PSA(L155)/TRICOM Vaccine; Recombinant Vaccinia-PSA(L155)/TRICOM;

NCIt definition : A vaccine formulation consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA) and recombinant vaccinia virus encoding three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3 (TRICOM). Vaccination with PSA in combination with TRICOM may enhance antigen presentation, resulting in the augmentation of a cytotoxic T cell (CTL) immune response against tumor cells expressing PSA.;

UNII : 59WJ3TGA5K;

CAS number : 1225283-43-1; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1225283-43-1 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : PROSTVAC;

Molecule name : Prostvac-V;

NSC code : 717170;

Details


You can consult :


Nous contacter.
12/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.